Matches in SemOpenAlex for { <https://semopenalex.org/work/W3110985523> ?p ?o ?g. }
- W3110985523 endingPage "1213" @default.
- W3110985523 startingPage "1213" @default.
- W3110985523 abstract "Polymer-based solid microstructures (MSts) have the potential to significantly increase the quantity and range of drugs that can be administered across the skin. MSt arrays are used to demonstrate their capacity to bypass the skin barrier and enhance permeability by creating microchannels through the stratum corneum, in a minimally invasive manner. This study is designed to demonstrate the ability of MSts to exceed the current boundaries for transdermal delivery of compounds with different molecular weights, partition coefficients, acid dissociation constants, melting points, and water solubilities. In vitro permeation of a range of selected molecules, including acetyl salicylic acid (aspirin), galantamine, selegiline hydrochloride (Sel-HCl), insulin, caffeine, hydrocortisone (HC), hydrocortisone 21-hemisuccinate sodium salt (HC-HS) and bovine serum albumin (BSA) has been studied across excised porcine skin with and without poke and patch application of MSts. Permeation of the molecules was monitored using Franz diffusion cells over 24 h. MSts significantly increased the permeation of all selected molecules up to 40 times, compared to topical applications of the molecules without MSts. The greatest increase in permeation was observed for caffeine with 70 ± 8% permeation and the lowest enhancement was observed for HC with a 2.4 ± 1.3% increase in permeation. The highest obtained flux was BSA (8133 ± 1365 μg/cm2/h) and the lowest flux observed for HC (11 ± 4 μg/cm2/h). BSA and HC also showed the highest (16,275 ± 3078 μg) and the lowest (73 ± 47 μg) permeation amount after 24 h respectively. MSt-treated skin exhibits greatly increased permeation. The molecule parameters (size, acid dissociation constant, partition coefficient and solubility)—traditional hurdles associated with passive diffusion through intact skin—are overcome using MSt skin treatment." @default.
- W3110985523 created "2020-12-21" @default.
- W3110985523 creator A5001823899 @default.
- W3110985523 creator A5047414571 @default.
- W3110985523 creator A5049850456 @default.
- W3110985523 creator A5050634227 @default.
- W3110985523 creator A5061184994 @default.
- W3110985523 creator A5066776916 @default.
- W3110985523 creator A5074275409 @default.
- W3110985523 date "2020-12-15" @default.
- W3110985523 modified "2023-10-17" @default.
- W3110985523 title "Characterisation of Drug Delivery Efficacy Using Microstructure-Assisted Application of a Range of APIs" @default.
- W3110985523 cites W1541116624 @default.
- W3110985523 cites W1903010132 @default.
- W3110985523 cites W1933816788 @default.
- W3110985523 cites W1939309359 @default.
- W3110985523 cites W1967910633 @default.
- W3110985523 cites W1978365588 @default.
- W3110985523 cites W1979029958 @default.
- W3110985523 cites W1984305355 @default.
- W3110985523 cites W1986516915 @default.
- W3110985523 cites W1988197046 @default.
- W3110985523 cites W1993402424 @default.
- W3110985523 cites W1994348089 @default.
- W3110985523 cites W1996484138 @default.
- W3110985523 cites W2004667039 @default.
- W3110985523 cites W2013868881 @default.
- W3110985523 cites W2020816951 @default.
- W3110985523 cites W2021638902 @default.
- W3110985523 cites W2024833184 @default.
- W3110985523 cites W2041614413 @default.
- W3110985523 cites W2049074302 @default.
- W3110985523 cites W2055681082 @default.
- W3110985523 cites W2067461053 @default.
- W3110985523 cites W2079405291 @default.
- W3110985523 cites W2080430067 @default.
- W3110985523 cites W2080888762 @default.
- W3110985523 cites W2081159973 @default.
- W3110985523 cites W2084062570 @default.
- W3110985523 cites W2085338797 @default.
- W3110985523 cites W2087672402 @default.
- W3110985523 cites W2089940267 @default.
- W3110985523 cites W2117369764 @default.
- W3110985523 cites W2149208397 @default.
- W3110985523 cites W2160760798 @default.
- W3110985523 cites W2185483721 @default.
- W3110985523 cites W2335972983 @default.
- W3110985523 cites W2346209283 @default.
- W3110985523 cites W2518198082 @default.
- W3110985523 cites W2604800309 @default.
- W3110985523 cites W2605322593 @default.
- W3110985523 cites W2771690000 @default.
- W3110985523 cites W2789219370 @default.
- W3110985523 cites W2791230900 @default.
- W3110985523 cites W2791517561 @default.
- W3110985523 cites W2792737160 @default.
- W3110985523 cites W2794830426 @default.
- W3110985523 cites W2803793494 @default.
- W3110985523 cites W2899970640 @default.
- W3110985523 cites W2903909531 @default.
- W3110985523 cites W2933015126 @default.
- W3110985523 cites W2939159344 @default.
- W3110985523 cites W2954959386 @default.
- W3110985523 cites W2975835807 @default.
- W3110985523 cites W2980747750 @default.
- W3110985523 cites W2981469174 @default.
- W3110985523 cites W2997778262 @default.
- W3110985523 cites W3012020852 @default.
- W3110985523 cites W3015319443 @default.
- W3110985523 cites W3031769824 @default.
- W3110985523 cites W3039287317 @default.
- W3110985523 cites W3083987393 @default.
- W3110985523 cites W2738762611 @default.
- W3110985523 cites W3006343652 @default.
- W3110985523 doi "https://doi.org/10.3390/pharmaceutics12121213" @default.
- W3110985523 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7765163" @default.
- W3110985523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33333795" @default.
- W3110985523 hasPublicationYear "2020" @default.
- W3110985523 type Work @default.
- W3110985523 sameAs 3110985523 @default.
- W3110985523 citedByCount "5" @default.
- W3110985523 countsByYear W31109855232021 @default.
- W3110985523 countsByYear W31109855232022 @default.
- W3110985523 crossrefType "journal-article" @default.
- W3110985523 hasAuthorship W3110985523A5001823899 @default.
- W3110985523 hasAuthorship W3110985523A5047414571 @default.
- W3110985523 hasAuthorship W3110985523A5049850456 @default.
- W3110985523 hasAuthorship W3110985523A5050634227 @default.
- W3110985523 hasAuthorship W3110985523A5061184994 @default.
- W3110985523 hasAuthorship W3110985523A5066776916 @default.
- W3110985523 hasAuthorship W3110985523A5074275409 @default.
- W3110985523 hasBestOaLocation W31109855231 @default.
- W3110985523 hasConcept C120882062 @default.
- W3110985523 hasConcept C142724271 @default.
- W3110985523 hasConcept C185592680 @default.
- W3110985523 hasConcept C205679159 @default.
- W3110985523 hasConcept C2778221352 @default.
- W3110985523 hasConcept C2778370115 @default.